Acute myeloid leukaemia+1
Not recruitingStudy of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders
Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders
- Disease:Acute myeloid leukaemiaMyelodysplastic syndrome
- Substances:BusulfanFludarabine Phosphate+1
France- Participants:18–64 years · 65+ years
- Substances:Busulfan







